doi: 10.3892/mmr.2014.2734 81 ChenZHuangCMaTJiangLTangLShiTet al
It essentially adds extra adaptation time before reaching therapeutic doses
Canadian drug manufacturers and distributors say they are not negotiating with Florida on its plan to import cheaper prescription drugs from Canada, contradicting claims from Florida that they are working diligently to negotiate with Canadian manufacturers. Innovative Medicines Canada has not spoken to Florida about this, and to our knowledge, neither have our members." The program, approved by the FDA in 2024, has yet to ship a single drug, despite costing the state $80 million
Neyestani TR, Shariatzadeh N, Gharavi A, Kalayi A, Khalaji N
Friebe, P., Lohmann, V., Krieger, N